Our portfolio

Nano Hybrids

Nano Hybrids has developed a novel technology that enables the one-step synthesis of a broad range of inorganic/organic core/shell nanoparticles without the use of solvents and additives. This innovative approach enhances efficiency, sustainability, and product purity, making it a significant advancement in nanomaterials. Nano Hybrids is committed to advancing nanotechnology through sustainable and efficient solutions.

Industry: Biotechnology, Chemistry, Nanomaterials

Want to get in contact about Nano Hybrids?

We’re happy to connect. Reach out to our investment manager working with the team to learn more or explore potential opportunities.

Ross Gordon

Chemistry, Biotech & AI

Our portfolio

Check out similar ventures

Reducing plastic waste and lowering CO2 emissions.
Enabling standard spectrometers to simultaneously measure both chemical composition and particle size by integrating patented, cost-effective Optical-DOSY flow cells.
Boosting recovery and confidence in elderly hip fracture patients with data-driven rehabilitation technology.
Developing gene therapy solutions for heart rhythm disorders.
Reducing plastic waste and lowering CO2 emissions.
Enabling standard spectrometers to simultaneously measure both chemical composition and particle size by integrating patented, cost-effective Optical-DOSY flow cells.
Boosting recovery and confidence in elderly hip fracture patients with data-driven rehabilitation technology.
Developing gene therapy solutions for heart rhythm disorders.